Biotech - Publications - Faculty & Research

11 Apr 2011
Lessons from the Classroom

Teaching a ‘Lean Startup’ Strategy

in the clean tech and biotech fields, both of which often require a great deal of time and capital to create any workable product. The same is true of the transportation industry—inventor Dean Kamen's Segway, for example, or startup... View Details

Keywords: by Carmen Nobel; Technology; Computer

02 Apr 2001
Research & Ideas

Not All M&As Are Alike—and That Matters

Scenario 4: The M&a As R&d The next-to-last category, acquisitions as a substitute for in-house R&D, is related to product and market extensions, but I'll treat it separately because it's so new and untested. An assortment of high-tech and View Details

Keywords: by Joseph L. Bower

30 Jun 2021
In Practice

The Harvard Business School Faculty Summer Reader 2021

many products and offer countless tips on how to lower your carbon footprint every day. Julia Austin (@austinfish) is an executive fellow at the Rock Center for Entrepreneurship and a former senior lecturer. Jeffrey Bussgang: Civil rights and View Details

Keywords: by Kathryn Haviland

15 Jun 2007
Research & Ideas

Remembering Alfred Chandler

School, Al was just publishing Scale and Scope. I watched him move from this book, which dealt principally with Second Industrial Revolution industries, to a keen interest in telecommunications and the Information Revolution. Before long, Al was digging into View Details

Keywords: by Sean Silverthorne

07 Feb 2005
Research & Ideas

How “Career Imprinting” Shapes Leaders

top biotech managers, companies leave an imprint of their worldview on young executives through such things as the firm's structure, strategy, and culture. There is a GE imprint, an IBM imprint, a Bain imprint—all of which influence... View Details

Keywords: by Mallory Stark

15 Feb 2000
Research & Ideas

The Right Connections

capital on their ability to secure resources. "In biotech it can take eight to ten years to develop a product and cost hundreds of millions of dollars to bring it to market," says Higgins. "Therefore, funding is... View Details

Keywords: by Judith A. Ross

02 Aug 2004
Research & Ideas

Health Care Research and Prospects

research projects. A: There is a whole bunch of work being done on biotech, the biotech industry, and the future of pharmaceuticals. My stuff looks at a broader question: Can science be a business? This is the history of biotech, which is... View Details

Keywords: by Wendy Guild Swearingen; Health

18 Oct 2010
Lessons from the Classroom

Venture Capital’s Disconnect with Clean Tech

MBA students often fall into one of two categories—those hungry to rush into careers as venture capitalists, and those eager to found a venture-funded start-up. For all of them, Harvard Business School professor Joseph Lassiter has some intriguing advice: Spend a few... View Details

Keywords: by Carmen Nobel; Energy; Utilities; Financial Services

03 Dec 2001
Research & Ideas

Healthcare Conference Looks At Ailing Industry

Jeffrey Wiesen, an attorney specializing in biotechnology, the standard routine was "more a work-for-hire model than a collaboration model, although we always called it collaboration." In a nutshell, it worked like this, Wiesen said. "A View Details

Keywords: by Martha Lagace; Health

09 Aug 2010
Research & Ideas

How to Speed Up Energy Innovation

something like that in energy, which is particularly interesting in areas like conservation. Biotech and pharma are more dependent on patents than energy is likely to be; but one of the most important things we learned from looking at... View Details

Keywords: by Julia Hanna; Energy; Utilities

19 Sep 2012
Research & Ideas

Funding Innovation: Is Your Firm Doing it Wrong?

its traditional slow-paced and bureaucratic system of R&D to emulate the relatively fast pace and entrepreneurial system of biotech companies." The firm created several specialized research teams to manage the innovation process.... View Details

Keywords: by Carmen Nobel

26 Nov 2001
Research & Ideas

Women Entrepreneurs Use Springboard for Funding

personalize healthcare and benefits, and Carol Nacy of Sequella, Inc., a biotech firm focused on controlling global infectious diseases, especially tuberculosis. Most of the companies were already up and running. Their funding to date has... View Details

Keywords: by Martha Lagace

06 May 2008
First Look

First Look: May 6, 2008

Fibrosis Foundation: Venture Philanthropy Funding for Biotech Harvard Business School Case 808-005 In 2001, Vertex Pharmaceuticals Incorporated acquired the San Diego-based biotech company, Aurora... View Details

Keywords: Martha Lagace

12 Oct 2006
First Look

First Look: October 12, 2006

http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707438 PublicationsScience Business: Promise, Performance and the Future of Biotech Author:Gary P. Pisano Publication:Harvard Business School Press (forthcoming) Abstract... View Details

Keywords: Sean Silverthorne

20 Jul 2015
Research & Ideas

Globalization Hasn’t Killed the Manufacturing Cluster

the federal government to create new clusters in the United States. He points to the rise of biotech in Harvard's backyard, which began despite government opposition in the 1970s. Clusters "tend to emerge much more organically, and they... View Details

Keywords: by Roberta Holland; Manufacturing; Apparel & Accessories; Fashion

06 Feb 2007
First Look

First Look: February 6, 2007

Harvard Business School Supplement 107-049 Supplements the (A) case. Purchase this supplement: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=107049 Monsanto: Realizing Biotech Value in Brazil Harvard Business School Case... View Details

Keywords: Martha Lagace

17 Oct 2006
First Look

First Look: October 17, 2006

founded by a young venture capitalist and a university professor to exploit recombinant DNA technology. Thirty years and more than $300 billion in investments later, only a handful of biotech firms have matched Genentech's success or even... View Details

Keywords: Sean Silverthorne

01 Jun 2009
Lessons from the Classroom

The Challenges of Investing in Science-Based Innovation

science-based research is something the heads of top biotech and pharmas learned long ago: There are few instant payoffs to please investors. Just ask Raymond Gilmartin, former chairman, president, and CEO of Merck & Co., who now... View Details

Keywords: by Julia Hanna; Banking; Auto; Pharmaceutical

17 Dec 2001
Research & Ideas

Enterprising Women

by the firm's mission and saw that it had been self-sufficient for nearly seven years, Fisher's task became much easier: In three stages, over the course of 2000, she raised venture capital funds of $11 million, $48 million, and $75 million. That same year, she founded... View Details

Keywords: by Julia Hanna

01 Mar 2018
What Do You Think?

Two Decades Later, is the 'New Economy' Finally Here?

second of these books, Exponential Organizations (“ExOs”), explores the impact of new technologies on organizations. These are organizations driven by such things as AI, robotics, biotech and bioinformatics, data science, and 3D printing.... View Details

Keywords: by James Heskett

Publications